Andrew Hessel, Genomic Futurist

Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is a Distinguished Researcher with Autodesk Inc.’s Bio/Nano Programmable Matter group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

Trained in microbiology and genetics, Andrew has continually worked at the forefront of genomics, first to read and comprehend bacterial, human, and other genomes and more recently to write them. He believes the technology that makes this possible, called synthetic biology, is revolutionary and that it will eventually surpass information technology (IT) as an economic engine and driver of societal change. He speaks widely on topics that include cells as living computers, life science as an emerging IT industry, and biological safety and security.

More Posts:

Toyota FT-Bh
2013 Ford Fusion Lane Keeping System
Breitling Praetorian Will Make Celebs Shine Brighter
iPhone 5 Commercial (Concept)
Super Compact Bike
Meet OutRunner: The World's First Remotely Controlled Running Robot
A Wearable Camera That Would Turn Into a Drone and Fly Off Your Wrist
AI at WIRED2014: The Next Big Frontier Is The Mind And Brain
Nicholas Negroponte: Nanobots in Your Brain Could Be the Future of Learning
Michio Kaku: Can We Download Our Brains?